Approval · Notice of Compliance 15490 · 2014
PARVOLEX: Notice of Compliance 15490
Issued April 11, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15490
- Date
- April 11, 2014
- Company
- Mylan Pharmaceuticals UlcEtobicoke, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Mucolytic, antidote for acetaminophen poisoning
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PARVOLEX | 02181460 | Cancelled Post Market |
Medicinal ingredients
- ACETYLCYSTEINE 200 MG per ML